The manuscript addresses the 3D chromatin architecture in monocytes from patients with alcohol-associated hepatitis and its relationship to enhanced transcription of innate immune genes. While the ...

MASH, which was previously known as non–alcohol related steatohepatitis (NASH), is often asymptomatic or leads to nonspecific symptoms, making progression to more severe stages of liver disease ...

Alcohol is a part of many people’s lives and can be hard to avoid. However, drinking more than the recommended amount can be harmful to your heart and general health. While there is no completely safe ...

By Sriparna Roy (Reuters) -Akero Therapeutics shares gained 106% before the bell on Monday, after its lead drug showed it can help patients with a type of liver disease to reverse scarring of the ...

If you drink heavy amounts of alcohol for weeks, months, or years, you may have mental and physical symptoms when you stop or cut back. This is called alcohol withdrawal. About half of all people ...

Choosing not to drink alcohol can sometimes lead to awkward social situations or unwanted pressure. But there are plenty of ways to decline a drink, allowing you to stick to your personal ...

Altimmune, Inc. (NASDAQ:ALT), a biopharmaceutical company with a market capitalization of $503.56 million focused on developing treatments for liver disease and obesity, has been garnering attention ...

Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic steatohepatitis (“NASH”), hepatocellular carcinoma (“HCC”) ...

Non-alcoholic steatohepatitis (NASH) is a condition characterized by accumulation of fat, inflammation and injury in liver cells in people who consume little or no alcohol. It is the progressive ...

Alcohol is the intoxicating ingredient that is present in wine, beer, and spirits. It is a depressant, which means that when it reaches the brain, it slows down the body’s systems. The short ...